Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

Lancet
Thomas EngstrømDANAMI-3—PRIMULTI Investigators

Abstract

Patients with acute ST-segment elevation myocardial infarction (STEMI) and multivessel coronary disease have a worse prognosis compared with individuals with single-vessel disease. We aimed to study the clinical outcome of patients with STEMI treated with fractional flow reserve (FFR)-guided complete revascularisation versus treatment of the infarct-related artery only. We undertook an open-label, randomised controlled trial at two university hospitals in Denmark. Patients presenting with STEMI who had one or more clinically significant coronary stenosis in addition to the lesion in the infarct-related artery were included. After successful percutaneous coronary intervention (PCI) of the infarct-related artery, patients were randomly allocated (in a 1:1 ratio) either no further invasive treatment or complete FFR-guided revascularisation before discharge. Randomisation was done electronically via a web-based system in permuted blocks of varying size by the clinician who did the primary PCI. All patients received best medical treatment. The primary endpoint was a composite of all-cause mortality, non-fatal reinfarction, and ischaemia-driven revascularization of lesions in non-infarct-related arteries and was assessed when the las...Continue Reading

References

Sep 28, 2000·The New England Journal of Medicine·J A GoldsteinW W O'Neill
Jan 16, 2009·The New England Journal of Medicine·Pim A L ToninoUNKNOWN FAME Study Investigators
Jul 31, 2009·Coronary Artery Disease·Saman RasoulUNKNOWN Zwolle Myocardial Infarction Study Group
Jun 3, 2010·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Ankur SethiSandeep Khosla
Jun 15, 2010·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Jan-Henk E DambrinkHarry Suryapranata
Jan 15, 2011·JACC. Cardiovascular Interventions·Argyrios NtalianisBernard De Bruyne
Sep 17, 2011·European Heart Journal·Jacob LønborgThomas Engstrøm
Sep 11, 2012·Journal of the American College of Cardiology·Kristian ThygesenDaniel R Wagner
Feb 22, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Damian J KellyAnthony H Gershlick
Sep 3, 2013·The New England Journal of Medicine·David S WaldUNKNOWN PRAMI Investigators
Sep 2, 2014·The New England Journal of Medicine·Bernard De BruyneUNKNOWN FAME 2 Trial Investigators
Dec 1, 2012·Global Heart·Kristian ThygesenHarvey D White

❮ Previous
Next ❯

Citations

Feb 20, 2016·Journal of the American College of Cardiology·Adnan KastratiGjin Ndrepepa
Feb 13, 2016·Journal of Interventional Cardiology·Cindy L GrinesTheodore L Schreiber
Jan 3, 2016·Journal of the American College of Cardiology·Kevin R Bainey, Paul W Armstrong
Feb 7, 2016·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Peter Ong, Udo Sechtem
Jan 5, 2016·Circulation Journal : Official Journal of the Japanese Circulation Society·Kenichi TsujitaHisao Ogawa
Jan 16, 2016·European Heart Journal·Ronald K BinderThomas F Lüscher
Jan 5, 2016·European Heart Journal·Gilles Montalescot, Filippo Crea
Dec 9, 2015·Journal of Interventional Cardiology·Ciprian BlendeaMonica Chiţu
Mar 10, 2016·Internal and Emergency Medicine·Giuseppe Di PasqualePietro Sangiorgio
Oct 29, 2015·The American Journal of Cardiology·Franz H MesserliStefano F Rimoldi
Jan 29, 2016·Heart·David M Shavelle
Sep 9, 2015·Lancet·Carlo Di Mario, Gareth Rosser
Jun 11, 2016·Journal of the American College of Cardiology·Nils P JohnsonViviany R Taqueti
Jun 10, 2016·Cardiology and Therapy·Claire McCuneIan B A Menown
Jun 25, 2016·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Saurav ChatterjeeJay Giri
Jul 11, 2016·International Journal of Cardiology·David C TongJamie Layland
Jul 28, 2016·Trends in Cardiovascular Medicine·Michael P Thomas, Eric R Bates
Jul 28, 2016·Trends in Cardiovascular Medicine·Jae Yoon ParkJoerg Herrmann
Jun 7, 2016·Expert Review of Cardiovascular Therapy·Massimo ManconeRoberto Diletti
Aug 10, 2016·Lancet·Grant W ReedChristopher P Cannon
Aug 16, 2016·Journal of the American College of Cardiology·Gabor G TothBernard De Bruyne
Sep 2, 2016·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Bertrand N MuketeThierry H Le Jemtel
Sep 3, 2016·Journal of the American College of Cardiology·Eric R BatesGlenn N Levine
Sep 8, 2016·The New England Journal of Medicine·Stuart J Pocock, Gregg W Stone
Sep 10, 2016·Journal of the American College of Cardiology·William F FearonNico H J Pijls
Oct 21, 2016·Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions·Islam Y ElgendyAnthony A Bavry
Oct 4, 2016·Archives of Cardiovascular Diseases·Gilles Rioufol, Gérard Finet
Oct 8, 2016·Journal of the American College of Cardiology·José P S HenriquesUNKNOWN EXPLORE Trial Investigators
Oct 17, 2016·JACC. Cardiovascular Imaging·Sara GaurBjarne L Nørgaard
Nov 21, 2016·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Golnaz SadjadiehLene Holmvang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.